Status:
COMPLETED
Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis
Lead Sponsor:
Hasselt University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Exercise therapy and increased physical activity in persons with Multiple Sclerosis (MS) improves mobility, muscular strength, physical fitness and fatigue without increasing relapse rate. As such, ph...
Detailed Description
Following inclusion, baseline measurements (PRE) will be performed in MS patients (n=80). First, static(isometric) muscle strength (dynamometry), exercise capacity (maximal graded exercise test) and b...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis Multiple Sclerosis.
- Healthy control.
- Aged \>18y.
- Written informed consent.
- Exclusion criteria:
- Contraindications to perform moderate to high intensity exercise.
- Participation in another study.
- Experienced acute MS related exacerbation \<6 months prior to start of the study
- EDSS score \> 6
Exclusion
Key Trial Info
Start Date :
January 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2019
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03803800
Start Date
January 9 2019
End Date
December 9 2019
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hasselt University
Diepenbeek, Limburg, Belgium, 3590